Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review
- PMID: 38001761
- PMCID: PMC10669212
- DOI: 10.3390/antiox12111907
Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review
Abstract
Ganoderma lucidum (G. lucidum) has been known for many centuries in Asian countries under different names, varying depending on the country. The objective of this review is to investigate the scientific research on the natural active bio-compounds in extracts obtained from G. lucidum with significant biological actions in the treatment of cancer. This review presents the classes of bio-compounds existing in G. lucidum that have been reported over time in the main databases and have shown important biological actions in the treatment of cancer. The results highlight the fact that G. lucidum possesses important bioactive compounds such as polysaccharides, triterpenoids, sterols, proteins, nucleotides, fatty acids, vitamins, and minerals, which have been demonstrated to exhibit multiple anticancer effects, namely immunomodulatory, anti-proliferative, cytotoxic, and antioxidant action. The potential health benefits of G. lucidum are systematized based on biological actions. The findings present evidence regarding the lack of certainty about the effects of G. lucidum bio-compounds in treating different forms of cancer, which may be due to the use of different types of Ganoderma formulations, differences in the study populations, or due to drug-disease interactions. In the future, larger clinical trials are needed to clarify the potential benefits of pharmaceutical preparations of G. lucidum, standardized by the known active components in the prevention and treatment of cancer.
Keywords: Ganoderma lucidum; antioxidant; antitumor activity; cytotoxic; immunomodulatory; natural bio-compounds; polysaccharides; triterpenoids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









References
-
- Soccol C.R., Bissoqui L.Y., Rodrigues C., Rubel R., Sella S.R., Leifa F., De Souza Vandenberghe L.P., Soccol V.T. Pharmacological Properties of Biocompounds from Spores of the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes): A Review. Int. J. Med. Mushrooms. 2016;18:757–767. doi: 10.1615/IntJMedMushrooms.v18.i9.10. - DOI - PubMed
-
- Zheng W. Drug discovery from fungal metabolites: A review of the papers in this monographical issue of Mycosystema concerned with the natural resources, problems and strategies. Mycosystema. 2011;30:151–157.
Publication types
LinkOut - more resources
Full Text Sources